Procter & Gamble (PG) Offering Possible 7.3% Return Over the Next 31 Calendar Days

Procter & Gamble's most recent trend suggests a bullish bias. One trading opportunity on Procter & Gamble is a Bull Put Spread using a strike $150.00 short put and a strike $140.00 long put offers a potential 7.3% return on risk over the next 31 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $150.00 by expiration. The full premium credit of $0.68 would be kept by the premium seller. The risk of $9.32 would be incurred if the stock dropped below the $140.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Procter & Gamble is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Procter & Gamble is bullish.

The RSI indicator is at 66.6 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Procter & Gamble

Putnam Asset Allocation Funds Buys Anthem Inc, Moderna Inc, Target Corp, Sells Procter & …
Sun, 19 Dec 2021 13:38:02 +0000
Investment company Putnam Asset Allocation Funds (Current Portfolio) buys Anthem Inc, Moderna Inc, Target Corp, Colgate-Palmolive Co, McKesson Corp, sells Procter & Gamble Co, Altria Group Inc, Best Buy Co Inc, Eli Lilly and Co, Old Dominion Freight Line Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Putnam Asset Allocation Funds.

Goldman Sachs Variable Insurance Trust Large Cap Value Fund Buys Salesforce. …
Sat, 18 Dec 2021 03:38:03 +0000
Investment company Goldman Sachs Variable Insurance Trust Large Cap Value Fund (Current Portfolio) buys Salesforce.com Inc, Charles Schwab Corp, Ball Corp, MetLife Inc, General Mills Inc, sells Comcast Corp, Marsh & McLennan Inc, The Walt Disney Co, Packaging Corp of America, Global Payments Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Goldman Sachs Variable Insurance Trust Large Cap Value Fund.

P&G Recalls Some Aerosol Dry Conditioner, Shampoo Spray Products Citing Cancer Risk
Fri, 17 Dec 2021 18:57:20 +0000
Procter & Gamble Co (NYSE: PG) has issued a voluntary recall of some aerosol dry conditioner spray products and aerosol dry shampoo spray products. The products recalled are from Pantene, Aussie, Herbal Essences, and Waterl

P&G recalls some conditioner, shampoo sprays on finding carcinogens
Fri, 17 Dec 2021 18:42:51 +0000
The recall also includes products from its Aussie and Waterless brands made in the United States and some discontinued items from its Old Spice and Hair Food brands, in which P&G said it detected “unexpected levels” of benzene, a human carcinogen. P&G did not disclose the number of recalled products, which were distributed through retail and online outlets, but said they represented less than 1% of its overall hair care product portfolio. The company said it had not received any reports of adverse events related to the recall, but added that daily exposure to the level of benzene detected in the products would not be expected to cause negative health consequences.

P&G recalls some conditioner, shampoo sprays due to potential cancer risk
Fri, 17 Dec 2021 18:37:09 +0000
Procter & Gamble Co said on Friday it was voluntarily recalling some hair care products sold in the United States and Canada from its Pantene and Herbal Essences brands, due to the presence of a cancer-causing chemical. The consumer goods giant said https://refini.tv/3F8GY2H certain aerosol dry conditioners and shampoos from the brands as well as some discontinued items from Old Spice and Hair Food brands, had a human carcinogen called benzene. It can result in cancers including leukemia, blood cancer of the bone marrow and blood disorders which can be life-threatening, P&G said.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.